By Mauro Orru 
 

Sanofi SA and GlaxoSmithKline PLC signed a supply agreement with Gavi, the administrator of COVAX Facility, a mechanism for the procurement and distribution of Covid-19 vaccines, Sanofi said Wednesday.

The French pharmaceutical company said the two drugmakers intend to supply 200 million doses of their adjuvanted recombinant protein-based Covid-19 vaccine to the COVAX Facility.

 

Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94

 

(END) Dow Jones Newswires

October 28, 2020 02:35 ET (06:35 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Oct 2020 to Nov 2020 Click Here for more Sanofi Charts.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Nov 2019 to Nov 2020 Click Here for more Sanofi Charts.